136 related articles for article (PubMed ID: 269416)
1. Conformational requirements for dopamine-induced vasodilation.
Volkman PH; Kohli JD; Goldberg LI; Cannon JG; Lee T
Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3602-6. PubMed ID: 269416
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the cardiovascular actions of dopamine and epinine in the dog.
Itoh H; Kohli JD; Rajfer SI; Goldberg LI
J Pharmacol Exp Ther; 1985 Apr; 233(1):87-93. PubMed ID: 2858584
[TBL] [Abstract][Full Text] [Related]
3. Effects of ring fluorination on the cardiovascular actions of dopamine and norepinephrine in the dog.
Goldberg LI; Kohli JD; Cantacuzene D; Kirk KL; Creveling CR
J Pharmacol Exp Ther; 1980 Jun; 213(3):509-13. PubMed ID: 6894165
[TBL] [Abstract][Full Text] [Related]
4. Consistent unmasking of dopamine-induced dilation of the canine femoral vascular bed.
Listinsky JJ; Kohli JD; Goldberg LI
J Pharmacol Exp Ther; 1980 Dec; 215(3):662-7. PubMed ID: 6108364
[TBL] [Abstract][Full Text] [Related]
5. Dopamine vascular actions of N-substituted derivatives of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN).
Kohli JD; Goldberg LI; Nichols DE
Eur J Pharmacol; 1979 Jun; 56(1-2):39-44. PubMed ID: 467513
[TBL] [Abstract][Full Text] [Related]
6. Modification of cardiovascular actions of 2-amino-5,6-dihydroxytetralin by N,N-di-n-propyl substitution.
Kohli JD; Goldberg LI; McDermed JD
Eur J Pharmacol; 1982 Jul; 81(2):293-9. PubMed ID: 6126371
[TBL] [Abstract][Full Text] [Related]
7. N,N-Di-n-propyl dopamine: a qualitatively different dopamine vascular agonist.
Kohli JD; Goldberg LI; Volkman PH; Cannon JG
J Pharmacol Exp Ther; 1978 Oct; 207(1):16-22. PubMed ID: 702336
[TBL] [Abstract][Full Text] [Related]
8. Dopamine-like renal and mesenteric vasodilation caused by apomorphine 6-propylnorapomorphine and 2-amino-6, 7-dihydroxy-1,2,3,4-tetrahydronaphthalene.
Crumly HJ; Pinder RM; Hinshaw WB; Goldberg LI
Nature; 1976 Feb; 259(5544):584-7. PubMed ID: 1250405
[No Abstract] [Full Text] [Related]
9. Dopamine induced relaxation of isolated canine renal, mesenteric, and femoral arteries contracted with prostaglandin F2-alpha.
Goldberg LI; Toda N
Circ Res; 1975 Jun; 36(6 Suppl 1):97-102. PubMed ID: 236842
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
[TBL] [Abstract][Full Text] [Related]
11. Effects of dopamine receptor agonists and antagonists at peripheral neuronal and vascular dopamine receptors in the anaesthetised dog.
Hilditch A; Drew GM
J Cardiovasc Pharmacol; 1984; 6(3):460-9. PubMed ID: 6202973
[TBL] [Abstract][Full Text] [Related]
12. The actions of dopamine and of sulpiride on regional blood flows in the rat kidney.
Chapman BJ; Horn NM; Munday KA; Robertson MJ
J Physiol; 1980 Jan; 298():437-52. PubMed ID: 7359426
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the alpha adrenoceptor activity of dopamine, ibopamine and epinine in the pulmonary circulation of the dog.
Shebuski RJ; Fujita T; Smith JM; Ruffolo RR
J Pharmacol Exp Ther; 1987 Apr; 241(1):6-12. PubMed ID: 3033210
[TBL] [Abstract][Full Text] [Related]
14. Selective DA2 versus DA1 antagonist activity of domperidone in the periphery.
Kohli JD; Glock D; Goldberg LI
Eur J Pharmacol; 1983 Apr; 89(1-2):137-41. PubMed ID: 6861882
[TBL] [Abstract][Full Text] [Related]
15. [New dopamine agonists in cardiovascular therapy].
Girbes AR; Van Veldhuisen DJ; Smit AJ
Presse Med; 1992 Aug 29-Sep 5; 21(27):1287-91. PubMed ID: 1359528
[TBL] [Abstract][Full Text] [Related]
16. Structure activity relationships of N-substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors.
Kohli JD; Weder AB; Goldberg LI; Ginos JZ
J Pharmacol Exp Ther; 1980 May; 213(2):370-4. PubMed ID: 7365696
[No Abstract] [Full Text] [Related]
17. Inhibition of plasma cholinesterase prevents the dopamine DA-1 receptor mediated renal vasodilation produced by ibopamine.
Nichols AJ; Shebuski RJ; Ruffolo RR
Eur J Pharmacol; 1987 Sep; 141(3):515-8. PubMed ID: 3666046
[TBL] [Abstract][Full Text] [Related]
18. Beta-receptor subtypes in the canine coronary circulation.
Trivella MG; Broten TP; Feigl EO
Am J Physiol; 1990 Nov; 259(5 Pt 2):H1575-85. PubMed ID: 1978578
[TBL] [Abstract][Full Text] [Related]
19. Effect of ibopamine on diuresis and arterial blood pressure in anesthetized rats and its interactions with dopaminergic and alpha- and beta-adrenergic antagonists.
Ferrini R; Miragoli G
Arzneimittelforschung; 1986 Feb; 36(2A):323-6. PubMed ID: 2871844
[TBL] [Abstract][Full Text] [Related]
20. Comparison of effects of dopamine hydrochloride and dopexamine hydrochloride on abdominal and femoral hemodynamics in anesthetized dogs.
van Kesteren RG; Heethaar RM; Charbon GA; Heethaar J; Brouwer FA
Circ Shock; 1993 Jul; 40(3):227-33. PubMed ID: 8348685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
